Cardiology

How Many Cardiac Surgeries Are Performed Each Year? – New Study by iData Research

No comments
How Many Cardiac Surgeries Are Performed Each Year? – New Study by iData Research

According to a new cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States with projections for the number to reach 1.3M by 2029. The US Cardiac surgery market is growing rapidly driven by the growth of many underlying procedures. The number of cardiac

iData ResearchHow Many Cardiac Surgeries Are Performed Each Year? – New Study by iData Research
read more

A Closer Look at the Top 3 Competitors in the U.S. Cardiac Surgery Market

No comments
A Closer Look at the Top 3 Competitors in the U.S. Cardiac Surgery Market

Introduction The U.S. cardiac surgery market is a critical sector in the healthcare industry, responsible for providing innovative solutions to patients with heart conditions. In 2022, three prominent companies, Edwards Lifesciences, Abbott, and Medtronic, stood out as the top competitors in this market. Each of these companies has strategically positioned itself within various segments of

Emma MatrickA Closer Look at the Top 3 Competitors in the U.S. Cardiac Surgery Market
read more

Balancing Cost and Care: The Shift to Less Expensive Catheters in the U.S. Vascular Access Device Market

No comments
Balancing Cost and Care: The Shift to Less Expensive Catheters in the U.S. Vascular Access Device Market

In the ever-evolving landscape of healthcare, innovations and advancements continue to shape the way we approach patient care. One such transformation is occurring in the U.S. Vascular Access Device (VAD) Market, where a notable shift towards less expensive catheters is taking place. This transition is driven by a combination of concerns associated with traditional vascular

Emma MatrickBalancing Cost and Care: The Shift to Less Expensive Catheters in the U.S. Vascular Access Device Market
read more

Identifying the Driving Forces of the European Infusion Therapy Device Market

No comments
Identifying the Driving Forces of the European Infusion Therapy Device Market

The European Infusion Therapy Device Market demonstrates resilience in the face of economic uncertainties across the continent. Despite an impending recession, the market continues to grow steadily, driven by strong market drivers. In our blog, we delve into the factors propelling this growth, providing valuable insights on how businesses can leverage these drivers for success.

Dejan PopicIdentifying the Driving Forces of the European Infusion Therapy Device Market
read more

Strategies for Growth: Exploring the Leaders of the Global Interventional Cardiology Device Market

No comments
Strategies for Growth: Exploring the Leaders of the Global Interventional Cardiology Device Market

The Global Interventional Cardiology Device Market is poised to achieve a remarkable value of $13 billion by 2029. Despite the anticipated decline in prices over the forecast period, primarily driven by market consolidation and bundling, the market is experiencing steady growth and expansion. Developing countries have witnessed an improvement in healthcare accessibility and overall hospital

Dejan PopicStrategies for Growth: Exploring the Leaders of the Global Interventional Cardiology Device Market
read more

Capitalizing on Change: The U.S. Infusion Therapy Device Market Leaders

No comments
Capitalizing on Change: The U.S. Infusion Therapy Device Market Leaders

With the rising costs of healthcare, many patients are seeking treatment outside of hospitals, including in outpatient settings such as homecare and specialty clinics. As a result, the infusion therapy device market has experienced significant growth. Despite the increased cost per device due to lower purchasing power at these alternate care sites, demand for premium

Dejan PopicCapitalizing on Change: The U.S. Infusion Therapy Device Market Leaders
read more

Revolutionizing Coronary Artery Disease Diagnosis: The Rise of HeartFlow

No comments
Revolutionizing Coronary Artery Disease Diagnosis: The Rise of HeartFlow

HeartFlow, a California-based start-up that has developed artificial intelligence to diagnose and provide information on coronary artery disease (CAD) based on CT scans, has recently received a $215M financing round led and participated by Bain Capital Life Sciences. The company’s revolutionary products have gained FDA approval, with its first product receiving De Novo clearance in

Emma MatrickRevolutionizing Coronary Artery Disease Diagnosis: The Rise of HeartFlow
read more

The Future of Pacemakers and ICDs: Revolutionizing Cardiac Rhythm Management

No comments
The Future of Pacemakers and ICDs: Revolutionizing Cardiac Rhythm Management

The field of cardiac rhythm management and ablation is rapidly evolving with the emergence of new technologies. Over the past decade, there have been significant improvements in the capabilities and battery lifespan of pacemakers and ICDs. However, the advancements in this field are far from over. In the coming years, wireless technology is expected to

Emma MatrickThe Future of Pacemakers and ICDs: Revolutionizing Cardiac Rhythm Management
read more

Exploring the Growth of the Neuromodulation Market: Key Drivers and Trends

No comments
Exploring the Growth of the Neuromodulation Market: Key Drivers and Trends

Last year, more than 215,000 neuromodulation procedures were performed worldwide, with expectations that this number will climb to nearly 400,000 by 2029. Furthermore, it is expected that the market value will increase significantly from $4.9 billion to $8.2 billion during that same period. So, what’s driving this impressive market growth? Our latest global neurological devices

Emma MatrickExploring the Growth of the Neuromodulation Market: Key Drivers and Trends
read more

What’s Causing the Standstill in the European Interventional Cardiology Market?

No comments
What’s Causing the Standstill in the European Interventional Cardiology Market?

The European interventional cardiology market witnessed a minor decline in 2022 compared to the previous year, primarily attributed to low unit sales growth and extensive price erosion. This trend is expected to continue throughout the projected period, resulting in a slight contraction of the market by 2029. Despite the availability of numerous innovative devices, the

Emma MatrickWhat’s Causing the Standstill in the European Interventional Cardiology Market?
read more